Aragon-Ching JB, Gupta S, Grivas P, Park SH, et al. Avelumab first-line maintenance for advanced urothelial carcinoma: long-term outcomes from the JAVELIN Bladder 100 trial in patients with high body mass index or diabetes mellitus. ESMO Open 2026;11:107776.
PMID: 42284622